Stephen F. Mahoney

Insider Reports History

Location
Hamilton, Bermuda
Signature
/s/Jennifer Tousignant, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen F. Mahoney:

Company Role Class Num Shares Value Price $ Report Date Ownership
Viridian Therapeutics, Inc.\DE President and CEO, Director Restricted Stock Units 55,071 $1,718,949 $23.41 03 Mar 2026 Direct
Viridian Therapeutics, Inc.\DE President and CEO, Director Common Stock 33,349 $1,002,470 $30.06 03 Mar 2026 Direct
Magenta Therapeutics, Inc. Title: Chief Financial and Operating Officer Common Stock 17,264 $207,168 $12.00 30 Nov 2022 Direct
Viridian Therapeutics, Inc.\DE President and CEO, Director Stock Option (Right to Buy) 559,600 02 Mar 2026 Direct

Insider Reports Filed by Stephen F. Mahoney

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRDN Viridian Therapeutics, Inc.\DE 03 Mar 2026 1 $0 4/A President and CEO, Director 09 Mar 2026, 19:35
VRDN Viridian Therapeutics, Inc.\DE 02 Mar 2026 5 $0 4 President and CEO 04 Mar 2026, 18:56
VRDN Viridian Therapeutics, Inc.\DE 03 Mar 2025 2 $0 4 President and CEO, Director 04 Mar 2025, 21:14
VRDN Viridian Therapeutics, Inc.\DE 27 Sep 2024 1 +$499,262 4 President and CEO, Director 30 Sep 2024, 19:10
VRDN Viridian Therapeutics, Inc.\DE 30 Oct 2023 1 $0 4 President and CEO, Director 01 Nov 2023, 16:35
VRDN Viridian Therapeutics, Inc.\DE 30 Oct 2023 0 $0 3 President and CEO, Director 01 Nov 2023, 16:30
DNTH Magenta Therapeutics, Inc. 30 Nov 2022 1 +$2,820 4 Title: Chief Financial and Operating Officer 02 Dec 2022, 15:23
DNTH Magenta Therapeutics, Inc. 01 Aug 2022 1 $0 4 Title: Chief Financial and Operating Officer Exhibit 24.1: Power of Attorney 01 Aug 2022, 21:11
DNTH Magenta Therapeutics, Inc. 17 May 2022 1 $0 4 Title: Chief Financial and Operating Officer 19 May 2022, 16:19
DNTH Magenta Therapeutics, Inc. 15 Feb 2022 1 $0 4 Title: Chief Financial and Operating Officer 17 Feb 2022, 16:16
DNTH Magenta Therapeutics, Inc. 16 Sep 2021 1 -$38,603 4 Chief Financial and Operating Officer 20 Sep 2021, 17:02
DNTH Magenta Therapeutics, Inc. 14 Sep 2021 1 $0 4 Chief Financial and Operating Officer 16 Sep 2021, 19:41